Foley Partner Courtenay Brinckerhoff was quoted in an article titled “PTO Decision to Rescind Continuation, RCE Rules Applauded” in the October 23, 2009 issue of BNA’s Life Sciences Law & Industry Report. Brinckerhoff discusses the U.S. Patent and Trademark Office’s decision to rescind final rules limiting patent continuation and claims practice, noting that continuations and RCEs are often required in life sciences applications to obtain a scope of patent protection that adequately covers the invention. She adds that USPTO Director David Kappos’ comments that the Patent Office will work to implement improvements to make the USPTO more efficient signals positive changes that are needed to improve the U.S patent process and maintain the vibrancy and competitiveness of many U.S. industries.
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."